Logo

Piramal Pharma Ltd. Share Price

Piramal Pharma Ltd. (INR)200.362.7   (1.4%)

Exchange ScripsBSE543635NSEPPLPHARMAISININE0DK501011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Piramal Pharma Ltd. Performance

Market performance
Open price199
High207.29
Volumes8104339
Prev Close200.36
Low199
Closing date2025-03-06
Historical performance
1 Year High307.90
3 Year High307.90
5 Year High307.90
1 Year Low114.35
3 Year Low61.62
5 Year Low61.62

Piramal Pharma Ltd. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
26471
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
1487.45
Dividend Yield
Dividend Yield
0.01 %

Piramal Pharma Ltd. Investment Returns

1 Year
57.5%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Piramal Pharma Ltd. Technicals

IndicatorsValueSignal
5-DMA194.69Bullish
10-DMA202.53Bearish
20-DMA204.54Bearish
50-DMA225.51Bearish
100-DMA240.46Bearish
200-DMA210.74Bearish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters1717171717
Foreign Investors---------------
Domestic Investors1717171717
Public Investors418425359734306381297979292295
Government21122

Piramal Pharma Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2011225127581641
Operating Profit1371785331225515921
Interest4485344219821634
Depreciation7406676758625450
Profit Before Tax1793-120248509490
Consolidated Net Profit178-186537608350
Adjusted EPS----238

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1322911933118599946
Total Reserves65610558025510746103
Minority Interest------------
Total Non-Current Liabilities29288381202902625604
Total Liabilities152972144365127172107561
Capital Work in Progress5657852967323995
Total Assets152972144365127172107561

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities10045483976645976
Cash Flow from Investing Activities-4340-13388-18121-44799
Cash Flow from Financing Activitie-42248178794239768
Net Cash Inflow / Outflow1482-371-2515945
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 1487.45.
  • 3Y Stock Price CAGR of the stock is 3.9.
  • The stock has a beta of 0.8.
  • In the last financial year, the company had an EBITDA of ₹13717 Million.
  • The company generated revenue of ₹81712 Million in the previous financial year.

Piramal Pharma Ltd.

200.362.7   (1.4%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1578881
No. of Shares: 7880.2
Performance:57.9%
P/L: ₹578881
Top Gainers
SymbolChange%
CAPTRUST90.93(20%)
KOHINOOR37.67(18%)
SOMICONVEY154.25(17%)
KECL142.08(16%)
LANCORHOL25.97(16%)
Top Losers
SymbolChange%
GENSOL334.8(-10%)
BBTCL147.13(-6%)
FOODSIN93.85(-6%)
ANSALAPI5.25(-5%)
AGSTRA16.25(-5%)
INFOMEDIA6.12(-5%)
MEP2.08(-5%)
COFFEEDAY31.48(-5%)
Similar stocks

Glaxosmithkline Pharmaceuticals Ltd.

19

2690.2

February 6 - March 6

Aarti Pharmalabs Ltd.

9.9

746.95

February 6 - March 6

Gland Pharma Ltd.

7.4

1629.95

February 6 - March 6

Abbott India Ltd.

6.5

30983.2

February 6 - March 6

Sanofi Consumer Healthcare India Ltd.

2.3

4813.9

February 6 - March 6

Suven Pharmaceuticals Ltd.

-0.1

1164.6

February 6 - March 6

Cipla Ltd.

-0.7

1461.75

February 6 - March 6

Bafna Pharmaceuticals Ltd.

-1.5

78.47

February 6 - March 6

Announcing Stock of the Month!

Stock of the Month
Stock of the Month